Benzinga's Top Downgrades

by Lisa Levin, Benzinga Editor

December 11, 2014 9:03 AM | 1 min read | Make a Comment

Analysts at Credit Suisse downgraded United Therapeutics

UTHR

from Neutral to Underperform. The price target for United Therapeutics has been raised from $100 to $120. United Therapeutics' shares closed at $131.42 yesterday. Analysts at UBS downgraded The Travelers Companies

TRV

from Buy to Neutral. The price target for Travelers has been raised from $101 to $105. Travelers' shares closed at $104.26 yesterday. Analysts at Deutsche Bank downgraded Macerich Company (The)

MAC

from Buy to Hold. The price target for Macerich is set to $78. Macerich's shares closed at $82.11 yesterday. Analysts at Sterne Agee downgraded Approach Resources

AREX

from Neutral to Underperform. The price target for Approach Resources is set to $4. Approach Resources' shares closed at $6.05 yesterday.

Market News and Data brought to you by Benzinga APIs